Stephanie Lagarde
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia.
Journal: Cancer research
Published: May 21, 2024
Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.
Journal: The Journal of experimental medicine
Published: February 14, 2023
Spectrum of Kidney Disorders Associated with T-Cell Immunoclones.
Journal: Journal of clinical medicine
Published: December 15, 2021
Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine.
Journal: PloS one
Published: April 27, 2020
Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 26, 2019
PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 28, 2018
PAX5A and PAX5B isoforms are both efficient to drive B cell differentiation.
Journal: Oncotarget
Published: August 11, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026